# 2026-09-03

Phase B ran once today: **08:38:23 CT** (the standard 8:35am scheduled run).
`execution.mode` is still `dry_run` in `risk_rules.json`, so the live-order
gate was closed regardless of outcome (and would have been closed anyway —
the dry-run cycle count is only 8 of the 10 required).

## Account state

No open equity positions. Account value $762.04, all of it cash. Because
nothing is held, the stop-loss, take-profit and conviction-trim checks had no
positions to run against this cycle, and there were no `exit_existing`
candidates from Phase A.

## Loss-limit check

Re-run fresh, as required every cycle: realized P&L is $0.00 today and $0.00
this week (0.0% / 0.0% of the $761.44 starting capital, against limits of 5%
daily and 10% weekly). **Entries not halted.**

## Candidates considered

`pending_proposals.jsonl` held the 2026-09-02 16:41:02 CT Phase A run
(`proposal_date` 2026-09-02): five `direction: long` candidates — GTLB
(medium), DELL (low, risk_flags: governance_history), VRT (high), MRVL
(low, risk_flags: dilution_risk), NVDA (high) — plus six `direction: avoid`
calls (GBTG, FRVO, INTC, MDB, AXTI, SPCX, not processed further) and no
`exit_existing` candidates. None had a prior `risk_check`/`order` entry with
matching `proposal_date`, so all five were evaluated fresh.

- **GTLB** — rejected: only 1 of 2 required consecutive cycles available
  (`thesis_stability`, first appearance in `thesis_history.jsonl`).
- **DELL** — thesis-stability stable (long across 2026-09-02 and 2026-09-01,
  conviction stable at low), but **rejected at the buy gate**: price gapped
  +13.84% above thesis-time price ($425.00 → $483.81), driven by DELL's
  post-earnings surge from $425.00 (09-01 close) to $492.20 (09-02 close) —
  well outside `entry_price_gap.max_pct` (3%).
- **NVDA** — thesis-stability stable (long across 2026-09-02 and 2026-09-01,
  conviction stable at high), but **rejected at the buy gate**: price gapped
  +3.86% above thesis-time price ($217.44 → $225.84), just outside the 3%
  ceiling.
- **VRT** — approved: thesis-stability stable (long across 2026-09-02 and
  2026-09-01, conviction stable at high), buy gate clear (gap +0.61%,
  extension -4.51% vs. 20d MA). Sized at **$152.41**.
- **MRVL** — approved: thesis-stability stable (long across 2026-09-02 and
  2026-09-01, conviction stable at low), buy gate clear (gap -3.89%,
  extension -9.90% vs. 20d MA, wash-sale check clean — MRVL's realized losses
  in account 506946300 are all 55+ days old, well outside the 30-day
  lookback). The -3.89% gap was re-checked against the thesis's invalidation
  criteria (Google-warrant dilution outpacing revenue, or further margin-
  guidance cuts) via a fresh news search — nothing found touches either
  trigger, so not invalidated. Sized at **$45.72** (risk_flags:
  dilution_risk).

VRT and MRVL together fill 2 of `max_concurrent_positions` 4, leaving
$563.91 cash (80%/74% cash buffer after each, both above the 10% minimum).

## Orders

Two buy orders reviewed, both `dry_run` (no live orders placed —
`execution.mode` is `dry_run`):

| Symbol | Side | Est. $ | Est. qty | Ask used |
|---|---|---|---|---|
| VRT | buy | $152.41 | 0.588842 | $258.83 |
| MRVL | buy | $45.72 | 0.224801 | $203.38 |

`review_equity_order` returned no blocking alerts for either.

Dry-run cycle count now **8** distinct dates (2026-08-24, 08-26, 08-27,
08-28, 08-31, 09-01, 09-02, 09-03) against the **10** required before the
live-order gate can open.

_(Convenience view only. `trade_log.jsonl` is the source of truth; if the two
disagree, trust `trade_log.jsonl`.)_
